Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z4VX
|
|||
| Former ID |
DIB006467
|
|||
| Drug Name |
BI 695501
|
|||
| Synonyms |
BI-695501)
Click to Show/Hide
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 3 | [1] | |
| Company |
Boehringer ingelheim pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02137226) BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.